Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

538
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
538
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

14
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
14
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

747
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
747
Cholera01:25

Cholera

40
Cholera is an acute gastrointestinal disease caused by the Gram-negative bacterium Vibrio cholerae. It is transmitted primarily via the fecal-oral route through the ingestion of contaminated water or food.Vibrio cholerae is a motile, Gram-negative bacterium of the family Vibrionaceae, primarily associated with waterborne outbreaks in areas with inadequate sanitation. Although over 200 serogroups of V. cholerae exist, only O1 and O139 are responsible for epidemic cholera. The O1 serogroup,...
40
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

855
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
855
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

696
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
696

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hantavirus infection in returned travellers: data from the GeoSentinel Network.

Journal of travel medicine·2026
Same author

Derivation and validation of clinical prediction models for viral etiologies of acute diarrhea in North American children presenting for emergency care.

medRxiv : the preprint server for health sciences·2026
Same author

Development and External Validation of a Prognostic Prediction Model for Hospitalization in SARS-CoV-2-Infected Ambulatory Patients.

Open forum infectious diseases·2026
Same author

Association between Weather Variables and Viral Gastroenteritis in the United States.

medRxiv : the preprint server for health sciences·2026
Same author

Estrogen Induced Regulation of Mucosal-Associated Invariant T Cells in Asthma.

Journal of immunology research·2026
Same author

Quantifying the population-level impact of expanded antibiotic treatment for cholera outbreak management.

PLoS computational biology·2026

Related Experiment Video

Updated: Mar 25, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.8K

Traveler's Diarrhea.

Stanley L Giddings1, A Michal Stevens1, Daniel T Leung2

  • 1Division of Infectious Diseases, Department of Medicine, University of Utah School of Medicine, 30 North 1900 East, Salt Lake City, UT 84132, USA.

The Medical Clinics of North America
|February 23, 2016
PubMed
Summary

Traveler's diarrhea (TD) is a common travel illness. Pretravel consultations can reduce TD incidence and impact through hygiene, vaccinations, and medication, preventing long-term health issues.

Keywords:
Antibiotic prophylaxisDiarrheaEpidemiologyProbioticsRisk factorsTravel

More Related Videos

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.
06:55

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.

Published on: November 7, 2018

9.6K
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

25.1K

Related Experiment Videos

Last Updated: Mar 25, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.8K
A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.
06:55

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.

Published on: November 7, 2018

9.6K
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

25.1K

Area of Science:

  • Public Health
  • Infectious Diseases
  • Travel Medicine

Background:

  • Traveler's diarrhea (TD) is the most frequent travel-related illness.
  • TD significantly impacts traveler well-being and experiences.
  • Potential postinfectious sequelae can arise weeks or months after travel.

Purpose of the Study:

  • To highlight the importance of pretravel consultations for managing traveler's diarrhea.
  • To discuss preventative strategies against traveler's diarrhea.
  • To inform about potential long-term health consequences of traveler's diarrhea.

Main Methods:

  • Review of current literature and clinical guidelines on traveler's diarrhea prevention and management.
  • Emphasis on pretravel counseling components including hygiene, vaccinations, and prophylactic/self-treatment medications.
  • Discussion of postinfectious sequelae associated with traveler's diarrhea.

Main Results:

  • Pretravel consultations are crucial for educating travelers on risk reduction.
  • Strategies like food/water hygiene, vaccinations, and medications can decrease TD incidence and severity.
  • Postinfectious complications such as IBS, reactive arthritis, and Guillain-Barre syndrome are recognized sequelae.

Conclusions:

  • Proactive traveler education and risk mitigation before travel are essential for preventing traveler's diarrhea.
  • Clinicians play a vital role in counseling travelers on appropriate preventive measures.
  • Awareness of potential long-term health effects underscores the importance of comprehensive traveler health management.